<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The HIV epidemic has challenged our previous understanding of endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Despite the strong association of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> in the Developed world, and against previous postulations that the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is due to immunosupression among African children, the HIV epidemic in the <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">Malaria</z:e> belt has not been associated with a corresponding increase in incidence of childhood Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Even outside the context of <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e>, there is substantial evidence for a strong but skewed immune response towards a TH2 response in genesis of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>PRESENTATION OF THE HYPOTHESIS: Rather than a global and/or profound immunosupression, the final common pathway in genesis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is the dysregulation of the immune response towards a TH2 response dominated by B-lymphocytes, and the concomitant suppression of the TH1 cell-mediated immune surveillance, driven by various <z:mp ids='MP_0001799'>viral</z:mp>/parasitic/<z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>TESTING THE HYPOTHESIS: Case control studies comparing TH2 and TH1 immune responses in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of different etiological types (<z:hpo ids='HP_0003745'>sporadic</z:hpo>, HIV-related, endemic and post-transplant) to demonstrate significant dominance of TH2 immune response in presence of poor CMI response as a common factor </plain></SENT>
<SENT sid="5" pm="."><plain>Immunological profiling to evaluate differences between immune states that are associated (such as recurrent <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">Malaria</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>) and those that are not associated (such as severe protein-energy <z:hpo ids='HP_0004395'>malnutrition</z:hpo>) with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Prospective cohorts profiling chronology of immunological events leading to Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in children with <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>IMPLICATIONS OF THE HYPOTHESIS: The dysregulation of the immune response may be the missing link in our understanding of Burkitt <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This will provide possibilities for determination of risk and for control of development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in individuals/populations exposed to the relevant <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
</text></document>